Treatment options when breast cancer becomes unresponsive to chemotherapy

UC expert speaks with Everyday Health

The University of Cincinnati's Mahmoud Charif was featured in an Everyday Health article discussing treatment options when metastatic triple-negative breast cancer (mTNBC) becomes unresponsive to chemotherapy.

Even though chemotherapy is the standard treatment for mTNBC, it’s not uncommon for these drugs to stop working eventually. 

Charif, MD, a University of Cincinnati Cancer Center member, associate professor in the UC College of Medicine and a UC Health physician, said breast cancer cells can become resistant to chemotherapy over time, making the treatment less effective. This is especially the case for mTNBC, which is typically a more aggressive form of cancer.

Treatment options when mTNBC becomes unresponsive to chemotherapy include immunotherapy, clinical trials and a class of drugs called antibody-drug conjugates (ADCs). Charif explained ADCs combine an antibody therapy and chemotherapy to work together to kill cancer cells.

Read the Everyday Health article.

Featured photo of 3D breast cancer cell courtesy of the National Cancer Institute.

Related Stories

2

UC co-op helps build career pathways at AtriCure

July 28, 2026

AtriCure, a global medical device company in Mason, Ohio, is UC’s largest biomedical engineering co-op employer, turning University of Cincinnati co-op students into full-time innovators.

3

CCM welcomes new musical theatre faculty member Avery Bargassé

July 28, 2026

UC College-Conservatory of Music Dean Pete Jutras has announced the appointment of Avery Bargassé as CCM's new Assistant Professor Educator of Musical Theatre Voice. His faculty appointment officially begins on Aug. 15, 2026. Bargassé is a versatile vocalist, recording artist and voice teacher whose career spans television, popular music and classical singing. He approaches teaching from a whole-person perspective, helping students develop healthy, flexible technique that supports expressive communication across styles.